Navigation Links
Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics
Date:10/1/2009

Reston, Va.SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19󈞁, 2009. The joint session, co-hosted by SNM and CMOD, will be held on Wednesday, Oct. 21, from 12:30 p.m. to 4:15 p.m.

"We are pleased to further extend our collaboration with the International Partnership for Critical Markers of Disease by holding this joint session on molecular imaging biomarkers in clinical research," said Michael Graham, PhD, MD, SNM president and director of nuclear medicine at the University of Iowa Carver College of Medicine. "We have established a vital scientific partnership to promote the expanded use and validation of molecular imaging biomarkers for clinical trials. Improved availability and performance of molecular imaging biomarkers will facilitate the development of safe and effective therapeutic drugs and ultimately enhance the delivery of personalized medicine."

"Our common interest in accelerating scientific research and therapeutic drug development by creating novel and advanced biomarkers to promote optimal health care today is a model for others to follow," said Therese Heinonen, DVM, executive director and co-founder of the International Partnership for Critical Markers of Disease and associate director of scientific affairs, Montreal Heart Institute Coordinating Center. "SNM and CMOD share the vision of expanding the use of these biomarkers in a standardized clinical research environment where providing high-quality, cost-effective patient care is the ultimate goal."

Peter Libby (co-founder of CMOD and Mallinckrodt Professor of Medicine at Harvard Medical School and chief of cardiovascular medicine at Brigham and Women's Hospital) will moderate the special afternoon session with Michael Graham. Don Black, general manager of molecular ima
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting
2. 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition
3. American Society of Plastic Surgeons hosts 78th annual meeting
4. American Society Of Plastic Surgeons Hosts 78th Annual Meeting
5. American Heart Association Meeting Report: High-Sugar Diet Increases Mens Blood Pressure; Gout Drug Protective
6. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. SpectraScience Announces Results of Annual Shareholder Meeting
9. Maternal/child health focus of African Science Academies meeting in Ghana Nov. 9-11
10. Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting
11. Dean MacCarter, Ph.D. Addressed Differentiation of Responder vs Non-Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Pwnie Express today announced the release ... Plug, the R3, an inconspicuous pentesting device whose drop ... remote locations at a fraction of the cost of ... the only company to assess wired and wireless network ... a next-generation penetration testing device in a portable, shippable, ...
(Date:9/3/2014)... 03, 2014 Morris Psychological ... free screenings for depression on October 9, 2014 ... Court). More than 1,000 organizations nationwide will be ... colleges and military installations. After completing a screening, ... and agencies that can offer further evaluation and ...
(Date:9/2/2014)... 03, 2014 Autumn is well ... to celebrate the new season with worldwide people. ... and announced that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), Arvixe, ... of 2014. , Since 2002 HostGator has ... and the company’s reputation for reliability remains with ...
(Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
(Date:9/2/2014)... 03, 2014 UWDress.com, an experienced supplier ... added a lot of fashionable bridesmaid dresses ... company has launched a special offer to celebrate the ... from 20 to 60 percent off. , The ... announce our new fashionable bridesmaid dresses for consumers from ...
Breaking Medicine News(10 mins):Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 2Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 3Health News:Pwnie Express Releases Next Generation Penetration Testing Device: The Pwn Plug R3 4Health News:Screenings for Depression by Morris Psychological Group, October 9, 2014 from 4:30 to 8:30pm, Rockaway Townsquare Mall (Macy’s Court) 2Health News:Top10BestSEOHosting.com Celebrates The Coming Of Autumn And Release Reseller Hosting Suppliers Of 2014 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2
... DENVER, July 28 ThinIdentity Corporation, a ... announced that Alegent Health is moving forward with plans ... The first installation is located at its Mercy Hospital ... has over 1,000 caregivers using the ThinIdentity solution to ...
... , WILMINGTON, Delaware, July 28 ... - 2014), published by,MarketsandMarkets ( http://www.marketsandmarkets.com ), the total drug-device,combination ... out of,which the U.S. market will account for nearly 30.9% ... a CAGR of 11.8% from 2009 to 2014. , ...
... ... CompactRIO embedded real-time platform at the 15th annual NIWeek, opening Aug. 4 at the ... and exhibition hosted by National Instruments. , ... Irvine, CA (PRWEB) July 27, 2009 -- MoviMED ( www.movimed.com ...
... ... find medical assistant training at All Allied Health Schools. , ... Seattle, Wash. (PRWEB) July 28, 2009 -- With current unemployment ... In 2006, the Bureau of Labor Statistics predicted 35 percent growth in medical assistant ...
... ... centers and healthcare facilities acquire financing for new and professionally refurbished medical equipment. , ... (Vocus) July 28, 2009 -- With ... to purchase medical equipment . DRE, Inc. — named a Company of the Year ...
... , ... Cleanroom wipers manufactured by Teknipure offer innovative ... to finish in one facility enabling maximum quality control and are ... Basis Weight, Sorbency, Liquid Particle Count, Non-Volatile Residue levels, Ionic Extractable ...
Cached Medicine News:Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 2Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 3Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 2Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 3Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 2Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 3Health News:Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 2Health News:Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 3Health News:Financing Available for Healthcare Equipment from DRE Medical Equipment 2Health News:Financing Available for Healthcare Equipment from DRE Medical Equipment 3Health News:Teknipure Cleanroom Wipers Offer Innovative Solutions for Contamination Control Engineers 2
(Date:9/2/2014)... 2014 Perrigo Company plc, a public limited company ... (the " Company "), today announced that it is offering ... new 1.30% Senior Notes due 2016 (the " 2016 Exchange ... 2018 (the " 2018 Exchange Notes "), $800,000,000 of its ... Notes ") and $400,00,000 of its new 5.30% Senior Notes ...
(Date:9/2/2014)... AUSTIN, Texas , Sept. 2, 2014 /PRNewswire/ ... Phase III study being conducted in the US ... a True Human™ monoclonal antibody therapy, is being ... is further complicated with cachexia. The primary endpoint ... in Xilonix treated patients to a control population ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 /PRNewswire/ ... report is available in its catalogue: ... 2014 http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html ... H2, 2014 Summary GlobalData,s clinical ... Review, H2, 2014" provides data on the Acute ...
Breaking Medicine Technology:Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8
... Work Status and,Productivity, WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ ... (DDW), from,long-term extensions of the ACT trials (Active ... moderately to severely active,ulcerative colitis (UC) who had ... the trials maintained,improvement in their clinical symptoms for ...
... WIRE)--May 23, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ: ... and commercializing small,molecule drugs to treat severe ... data from the Phase 2b clinical,trial in ... drug,candidate, STA-4783, will be presented at the ...
Cached Medicine Technology:Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
... Metrikas pager-sized A1cNow ... technology to provide healthcare ... access to quantitative A1C ... indicator of diabetes management ...
... Vein Treatment. It is estimated that 25% of ... veins. In the United States, more than half ... from painful and unsightly venous disease., The VenaCure ... vascular therapy for the treatment of varicose veins. ...
Inquire...
Inquire...
Medicine Products: